Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2026-02-03 @ 2:59 AM
Study NCT ID:
NCT03542435
Status:
COMPLETED
Last Update Posted:
2018-10-16
First Post:
2018-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized, Double-Blind, Placebo-Controlled, MAD Study to Assess the Safety, Tolerability, and Pharmacokinetics of SXC 2023
Sponsor:
Promentis Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Volunteers | View |
Keywords: